NOC vs TRAW · P/E 17, rev $20.76B vs rev $2.8M
Northrop Grumman Corporation (NOC) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the NOC and TRAW stock pages for the full models.
Not investment advice.